ATE173165T1 - Zusammensetzung, verfahren und instrument zur potenzierung der antitumoraktivität und zur behandlung von tumoren - Google Patents

Zusammensetzung, verfahren und instrument zur potenzierung der antitumoraktivität und zur behandlung von tumoren

Info

Publication number
ATE173165T1
ATE173165T1 AT92910345T AT92910345T ATE173165T1 AT E173165 T1 ATE173165 T1 AT E173165T1 AT 92910345 T AT92910345 T AT 92910345T AT 92910345 T AT92910345 T AT 92910345T AT E173165 T1 ATE173165 T1 AT E173165T1
Authority
AT
Austria
Prior art keywords
composition
antitumor activity
potentifying
instrument
treating tumors
Prior art date
Application number
AT92910345T
Other languages
English (en)
Inventor
Tetsuhiko Shirasaka
Masakazu Fukushima
Hideyuki Ohshimo
Yuji Shimamoto
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE173165T1 publication Critical patent/ATE173165T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT92910345T 1991-05-27 1992-05-22 Zusammensetzung, verfahren und instrument zur potenzierung der antitumoraktivität und zur behandlung von tumoren ATE173165T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12124791 1991-05-27

Publications (1)

Publication Number Publication Date
ATE173165T1 true ATE173165T1 (de) 1998-11-15

Family

ID=14806544

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92910345T ATE173165T1 (de) 1991-05-27 1992-05-22 Zusammensetzung, verfahren und instrument zur potenzierung der antitumoraktivität und zur behandlung von tumoren

Country Status (14)

Country Link
US (1) US5525603A (de)
EP (1) EP0543015B1 (de)
JP (1) JP2614164B2 (de)
KR (1) KR0148589B1 (de)
AT (1) ATE173165T1 (de)
AU (1) AU654555B2 (de)
CA (1) CA2087540C (de)
DE (2) DE122011100040I2 (de)
DK (1) DK0543015T3 (de)
ES (1) ES2124257T4 (de)
HU (1) HU211987A9 (de)
LU (1) LU91852I2 (de)
TW (1) TW209833B (de)
WO (1) WO1992021345A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5719132A (en) * 1996-06-27 1998-02-17 Bristol-Myers Squibb Company Compositions and methods of treating HIV with d4T, 5-fluorouracil/tegafur, and uracil
NZ330360A (en) * 1997-06-02 1999-03-29 Hoffmann La Roche 5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
JPH11116564A (ja) * 1997-10-09 1999-04-27 Otsuka Chem Co Ltd クロモン誘導体
US6005098A (en) * 1998-02-06 1999-12-21 Hoffmann-La Roche Inc. 5'deoxycytidine derivatives
RU2198171C2 (ru) * 1998-10-12 2003-02-10 Леонидов Николай Борисович Новая кристаллическая модификация 5-фтор-1-(тетрагидро-2-фурил)-урацила и комплексные соединения на ее основе, обладающие противоопухолевым действием
JP2002255828A (ja) * 2001-02-28 2002-09-11 Ajinomoto Co Inc 抗腫瘍剤
US20060089327A1 (en) * 2002-01-14 2006-04-27 Hohneker John A Combinations comprising epothilones and anti-metabolites
CA2518195C (en) * 2003-03-14 2009-07-07 Taiho Pharmaceutical Co., Ltd. Antitumor effect potentiator and antitumor agent
PT1750703E (pt) * 2004-04-29 2012-02-23 Taiho Pharmaceutical Co Ltd Processo destinado à redução da toxicidade gastrintestinal devida à administração de tegafur
KR100844477B1 (ko) 2004-06-09 2008-07-07 다이호야쿠힌고교 가부시키가이샤 항종양 효과 증강제, 항종양제 및 암 치료 방법
DE602006016576D1 (de) * 2005-04-01 2010-10-14 Taiho Pharmaceutical Co Ltd Strahlentherapieverstärker
JP4994618B2 (ja) * 2005-08-11 2012-08-08 学校法人北里研究所 Ｔｓ−１／カンプトテシン類による化学放射線療法
US8198264B2 (en) * 2006-04-28 2012-06-12 National Cancer Center Method for treating head and neck cancer
CN101921227B (zh) * 2007-04-03 2012-09-05 南京工业大学 5-氯-4-羟基-2(1h)-吡啶酮晶型及其制备方法和应用
TWI468188B (zh) 2008-01-30 2015-01-11 Univ Tokushima Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
AU2008356312B2 (en) 2008-05-12 2015-04-09 Shizuoka Prefecture Antitumor agent, kit, and method for treating cancer
EP2407786A4 (de) 2009-03-12 2013-01-02 Univ Kinki Verfahren zur vorhersage der wirksamkeit von chemotherapie bei nicht-kleinzelligem bronchialkarzinom
EP2415870B1 (de) 2009-03-31 2016-07-20 Delta-Fly Pharma, Inc. Rnai-molekül für thymidylatsynthase und verwendungen davon
JP5566376B2 (ja) * 2009-04-22 2014-08-06 大鵬薬品工業株式会社 腎細胞癌に対する化学療法の治療効果予測方法
JPWO2010131460A1 (ja) 2009-05-12 2012-11-01 大鵬薬品工業株式会社 テガフール・ギメラシル・オテラシルカリウム配合剤及びオキサリプラチンを含有する抗腫瘍剤
AU2010312594B2 (en) 2009-10-27 2013-06-20 Delta-Fly Pharma, Inc. Novel 5-fluorouracil derivative
CN102309491B (zh) * 2010-07-02 2015-06-10 天津金耀集团有限公司 一种替加氟、吉美斯特复方注射液
JPWO2012105486A1 (ja) 2011-01-31 2014-07-03 大鵬薬品工業株式会社 １日１回隔日投与を特徴とするテガフール含有組成物
JPWO2012157647A1 (ja) 2011-05-16 2014-07-31 大鵬薬品工業株式会社 胃癌患者に対するテガフール・ギメラシル・オテラシルカリウム配合剤及びｅｇｆｒ阻害剤からなる化学療法の選択方法
SG194922A1 (en) * 2011-05-25 2013-12-30 Taiho Pharmaceutical Co Ltd Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
CN103159673B (zh) * 2011-12-12 2015-02-04 山东新时代药业有限公司 一种制备吉美嘧啶的精制方法
AU2013233094A1 (en) 2012-03-16 2014-10-23 Taiho Pharmaceutical Co., Ltd. Novel antitumor agent comprising combination of three agents
WO2013180274A1 (ja) * 2012-06-01 2013-12-05 大鵬薬品工業株式会社 胃癌患者に対する化学療法の選択方法
CN114436822B (zh) * 2022-01-12 2024-04-16 厦门稀土材料研究所 一枝蒿酮酸和生物碱复盐及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55111420A (en) * 1979-02-20 1980-08-28 Ono Pharmaceut Co Ltd Antitumorigenic agent
JPS562913A (en) * 1979-06-21 1981-01-13 Ono Pharmaceut Co Ltd Antitumor agent
JPS5646867A (en) * 1979-09-25 1981-04-28 Ono Pharmaceut Co Ltd Pyridone derivative, its preparation and antineoplasmic agent
DK175432B1 (da) * 1984-10-30 2004-10-18 Otsuka Pharma Co Ltd Middel til forögelse af anticancervirkningen af anticancerforbindelser
JPS62155215A (ja) * 1984-11-30 1987-07-10 Otsuka Pharmaceut Co Ltd 抗腫瘍活性増強剤
NL194430C (nl) * 1989-01-05 2002-04-04 Otsuka Pharma Co Ltd Niet-injecteerbaar farmaceutisch preparaat met anti-kankerwerking.
JPH0578249A (ja) * 1991-09-20 1993-03-30 Taiho Yakuhin Kogyo Kk ５−フルオロウラシル類により起こる嘔気・嘔吐の防止及び治療剤

Also Published As

Publication number Publication date
JP2614164B2 (ja) 1997-05-28
KR0148589B1 (ko) 1998-11-02
CA2087540C (en) 1999-01-19
DE69227571T2 (de) 1999-04-29
DE69227571D1 (de) 1998-12-17
CA2087540A1 (en) 1992-11-28
EP0543015A4 (en) 1994-06-01
HU211987A9 (en) 1996-01-29
TW209833B (de) 1993-07-21
AU654555B2 (en) 1994-11-10
DE122011100040I1 (de) 2011-11-24
DE122011100040I2 (de) 2012-08-09
WO1992021345A1 (fr) 1992-12-10
EP0543015B1 (de) 1998-11-11
LU91852I2 (fr) 2011-10-03
DK0543015T3 (da) 1999-07-26
ES2124257T3 (es) 1999-02-01
AU1791292A (en) 1993-01-08
EP0543015A1 (de) 1993-05-26
US5525603A (en) 1996-06-11
ES2124257T4 (es) 2012-03-23

Similar Documents

Publication Publication Date Title
ATE173165T1 (de) Zusammensetzung, verfahren und instrument zur potenzierung der antitumoraktivität und zur behandlung von tumoren
ATE396988T1 (de) Chinolin- und chianzolinderivate zur behandlung von tumoren
DE69729946D1 (de) Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
ATE209199T1 (de) Chinolin und chinazolin derivate zur behandlung von arthritis
FI940414A (fi) Kinoliini- tai kinatsoliinijohdannaiset, niiden valmistus ja käyttö
DE69406323T2 (de) Substituierte Aminsäure Derivate verwendbar für die Behandlung von Arteriosclerosis
ATE402940T1 (de) Verfahren zur herstellung von 3-cephem- verbindungen
FI842533A (fi) Hexahydropyrrolo/2,1-a/isokinolin- derivat.
ATE283269T1 (de) 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
DE69327077D1 (de) Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
DK601883A (da) Phenyl-propanolderivater